АКЛАСТА

Produktübersicht

About АКЛАСТА

АКЛАСТА is a medication containing the active ingredient Zoledronic acid, a bisphosphonate used in the treatment of bone diseases. It is available in various forms, including injectable solutions, and is administered by a healthcare professional.

Key Benefits & Uses

• Treatment of osteoporosis in postmenopausal women, glucocorticoid-induced osteoporosis, and bone metastases in patients with malignancies.
• Prevention of skeletal events in patients with multiple myeloma and bone metastases from solid tumors.
• Management of hypercalcemia of malignancy.

Active Ingredient & Action

Zoledronic acid works by inhibiting osteoclast-mediated bone resorption, thereby reducing bone turnover and increasing bone density. It also has a direct antitumor effect on bone metastases, reducing the risk of skeletal events.

Important Notes

АКЛАСТА should only be administered under the guidance of a healthcare professional. Patients with certain medical conditions, such as renal impairment, should be closely monitored during treatment. Common side effects include hypocalcemia, flu-like symptoms, and bone pain.